Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.
暂无分享,去创建一个
D. Ma | J. Biggs | D. Varga | D. E. Varga | David D.F. Ma | James C. Biggs
[1] A. Faille,et al. Granulocyte progenitor compartments after allogeneic bone marrow grafts. , 2009, Scandinavian journal of haematology.
[2] B. Petersen. Constant post-irradiation repopulation rates and linear relationship between cellular blood response and number of transplanted bone marrow cells in inbred mice. , 2009, Scandinavian journal of haematology.
[3] E. Lemarié,et al. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. , 1986, Experimental hematology.
[4] R. Gale,et al. The early complications of bone marrow transplantation. , 1984, Seminars in hematology.
[5] A. Hoffbrand,et al. Differential cytotoxicity of deoxyguanosine and 8‐aminoguanosine for human leukemic cell lines and normal bone marrow progenitor cells , 1984, Hematological oncology.
[6] D. Neville,et al. EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE , 1984, The Lancet.
[7] G. Janossy,et al. DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS , 1984, The Lancet.
[8] J. Biggs,et al. Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anaemia , 1983, The Medical journal of Australia.
[9] J. Biggs,et al. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation , 1983, British journal of haematology.
[10] E. Gordon-Smith,et al. Regeneration of peripheral blood cells following allogeneic bone marrow transplantation for severe aplastic anaemia , 1982, British journal of haematology.
[11] R. Bast,et al. AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT , 1982, The Lancet.
[12] D. Ma,et al. Comparison of two methods for concentrating stem cells for cryopreservation and transplantation , 1982, Transfusion.
[13] W. Friedrich,et al. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. , 1982, Blood.
[14] D. Ma,et al. Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cells. , 1982, Cryobiology.
[15] B. Netzel,et al. Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses. , 1980, Experimental hematology.
[16] A. Zander,et al. The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation. , 1980, Blood.
[17] R. Storb,et al. Marrow transplantation for treatment of aplastic anaemia. , 1978, Clinics in haematology.
[18] R. Storb,et al. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. , 1977, The New England journal of medicine.